Young Faculty Angle For Funding Support

For scientists beginning their first year in their own lab, amassing sufficient startup funding can pose a tremendous challenge. This was not the case for organic chemist Eric Anslyn, however. Even before he began his first day as an assistant professor at the University of Texas in Austin last fall, he negotiated a package with the university that gave him $190,000 to equip and start up his lab. Then he won a $25,000 no-strings-attached award specifically designed for startup funding from the

Written byKathryn Phillips
| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share

For scientists beginning their first year in their own lab, amassing sufficient startup funding can pose a tremendous challenge. This was not the case for organic chemist Eric Anslyn, however. Even before he began his first day as an assistant professor at the University of Texas in Austin last fall, he negotiated a package with the university that gave him $190,000 to equip and start up his lab. Then he won a $25,000 no-strings-attached award specifically designed for startup funding from the New York-based Camille and Henry Dreyfus Foundation.

Once the academic year began, Anslyn won a state grant to pay for several students to work in his lab. And by springtime, he had added still more to his coffers with the receipt of a coveted National Science Foundation Presidential Young Investigator Award.

Now that's the best thing you can possibly get," says a very pleased Anslyn. After he collects ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies